Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Connected Pharmacy Platform to Improve Adherence to Buprenorphine- Naloxone Prescription Treatment of Opioid Use Disorder.

NCT04656899 is registered in ClinicalTrials.gov with Washington State University as lead sponsor.

NCT NCT04656899
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04656899 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Connected Pharmacy Platform to Improve Adherence to Buprenorphine- Naloxone Prescription Treatment of Opioid Use Disorder.
Lead sponsor
Washington State University
Phase
Not applicable
Overall status
Completed
Start date
December 6, 2020
Completion date
October 11, 2021
Enrollment
41 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

opioid-use disorder